Cinacalcet Tablet, Film Coated
Product Images NDC 84386-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cinacalcet (NDC 84386-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Mean (se) Ipth Values (pooled Phase 3 Studies) (Cinacalcet Fig1)

FDA Label Image

Figure 2. Mean (se) Ca X P Values (pooled Phase 3 Studies) (Cinacalcet Fig2)

FDA Label Image

Figure 3 (Cinacalcet Fig3)

FDA Label Image

Figure 4. Mean Serum Calcium (se) At Baseline, End Of Titration, And Scheduled Maintenance Visits (patients With Severe Intractable Primary Hpt) (Cinacalcet Fig4)

Figure 4. Mean Serum Calcium (se) At Baseline, End Of Titration, And Scheduled Maintenance Visits (patients With Severe Intractable Primary Hpt) (Cinacalcet Fig4)
This text appears to show a list of numbers related to maintenance work. The numbers may represent tasks, durations, or steps involved in the maintenance process. There are also some symbols and characters mixed in, hinting at technical information or instructions.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
The text provides information on a medication called Ginacalcet Hydrochloride, with each film-coated tablet containing 33 mg of the active ingredient, equivalent to 30 mg of cinacalcet. The product is distributed by Aurobindo Pharma USA, Inc. and is manufactured in India. The recommended storage temperature is 20° to 25°C (68° to 77°F). The packaging includes details like GTIN, Serial Number, Expiry Date, and LOT in human-readable format. Instructions for usual dosage are given in the package insert.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is a description of a medication labeled as Ginacalcet Hydrochloride distributed by Aurobindo Pharma USA, Inc. Each film-coated tablet contains 66 mg of Ginacalcet Hydrochloride, equivalent to 60 mg of cinacalcet. The tablets are to be stored at 20°C to 25°C and dispensed in a tight, light-resistant container per USP standards. The usual dosage information can be found in the package insert. NDC number and pharmaceutical company details are also provided.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY PANEL)

Package Label (PRINCIPAL DISPLAY PANEL)
This is details of Cinacalcet Tablets with NDC 84386-113-30. Each film-coated tablet contains Cinacalcet Hydrochloride 99 mg, equivalent to cinacalcet 90 mg. The recommended dosage should be as per the package insert guidelines. The tablets should be stored between 20°C to 25°C (68°F to 77°F). Dispensing should be done in a tight, light-resistant container as per USP guidelines. Made in India, distributed by Aurobindo Pharma USA, Inc. with the address at East Windsor, NJ. The package includes a coding area and relevant information will be printed during packing.*
FDA Label Image

Chemical Structure (Cinacalcet Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.